|
INC Research
is a therapeutically focused global contract research organization (CRO) with unrivaled expertise and a reputation for conducting global clinical development programs of the highest integrity.
Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in therapeutic areas of specialty, and in innovative pediatric and women's health trials. The company's The Trusted Process® methodology and therapeutic foresight leads customers to more confident, better-informed drug and device development decisions. 
|
| |
|  |
|
|
INC Research's Dr. Silvia Zieher Selected for PharmaVOICE 100 List
Director and Head of Clinical Operations in
Latin America Recognized for Providing Inspiration
to Life Sciences Industry
|
 |
|
Join Us for our September 15th Webinar:
The Value of Strategic Alliances vs. Transactional
CRO-Sponsor Relationships
With Tim Dietlin, VP of Alliance Development, INC Research,
and David Gillogly, Global Head, Clinical Contracting and
Category Management, Novartis
|
Click to register |
 |
|
|